4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-013889
Chief Financial Officer sold 3,000 shares at $11.05 ($33,150)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-02-24 | Sale | −3,000 | $11.05 | $33,150 | 114,201 | D |
| Open-market sales · 3,000 sh · avg $11.05 · $33,150 | |||||||
Loading xslF345X03/doc4.xml…